Procter & Gamble CO Form 4 insider transactions

NYSE
Procter & Gamble executive Sundar G. Raman reported the acquisition and disposal of company stock and restricted stock units, including transactions related to dividend equivalents and tax withholdings.
NYSE
Susan Whaley, Chief Legal Officer of Procter & Gamble, reported the acquisition and disposal of company stock and restricted stock units.
NYSE
Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, reported multiple transactions involving company stock and restricted stock units.
NYSE
Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, reports the acquisition and disposal of company stock and restricted stock units on December 19, 2024.
NYSE
Procter & Gamble's Chief Financial Officer, Andre Schulten, reported transactions involving company stock and restricted stock units.
NYSE
Procter & Gamble's CEO, Jon Moeller, reported the acquisition and disposal of company stock and restricted stock units, including transactions to cover tax obligations.
NYSE
Jennifer L. Davis, CEO of Health Care at Procter & Gamble, reported the acquisition and disposal of company stock and restricted stock units.
NYSE
Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reports changes in beneficial ownership of company stock due to tax withholding and dividend equivalents.
NYSE
Director Patricia A. Woertz acquired 175 shares of Procter & Gamble common stock through a restricted stock unit award.
NYSE
Robert Portman, an executive at Procter & Gamble, has been granted restricted stock units under the company's 2019 compensation plan.
NYSE
Ashley McEvoy, a Procter & Gamble executive, was granted common stock and restricted stock units under the company's 2019 compensation plan.
NYSE
Christine M. McCarthy, a Procter & Gamble executive, received restricted stock units under the company's 2019 compensation plan.
NYSE
Terry J. Lundgren, an executive at Procter & Gamble, reported the acquisition of restricted stock units and shares through dividend reinvestment.
NYSE
Director Christopher J. Kempczinski acquired 175 shares of Procter & Gamble common stock on December 10, 2024, through a grant of restricted stock units.
NYSE
Director Joseph Jimenez of Procter & Gamble acquired 276 shares of common stock through a restricted stock unit award.
NYSE
Director M. Brett Biggs of Procter & Gamble acquired 175 restricted stock units on December 10, 2024.
NYSE
Director B. Marc Allen acquired 175 shares of Procter & Gamble common stock on December 10, 2024, as part of a restricted stock unit award.
NYSE
Gary Coombe, a Procter & Gamble executive, executed multiple transactions involving company stock, including the acquisition and sale of shares and the vesting of restricted stock units.
NYSE
Procter & Gamble's Chief Human Resources Officer, Balaji Purushothaman, executed multiple stock transactions, including the acquisition and sale of common stock and the vesting of restricted stock units.
NYSE
Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, executed stock options and sold shares on October 24, 2024.
NYSE
Alexandra Keith, CEO Beauty at Procter & Gamble, reported the disposal of common stock held both directly and indirectly through retirement plans and spousal holdings on October 23, 2024.
NYSE
Alexandra Keith, CEO Beauty at Procter & Gamble, reported the sale of company stock on October 22, 2024.
NYSE
Director Amy Chang reports acquiring 1,309 shares of Procter & Gamble common stock through restricted stock units.
NYSE
Director Christine M. McCarthy reported acquiring 1,309 shares of Procter & Gamble common stock on October 8, 2024.
NYSE
Director Patricia Woertz reports acquisition of Procter & Gamble stock units through an incentive plan.
NYSE
Rajesh Subramaniam, a director at Procter & Gamble, acquired 1,309 shares of common stock through the company's stock and incentive compensation plan.
NYSE
Director Robert Portman reported the acquisition of 1,309 shares of Procter & Gamble common stock through restricted stock units and the disposal of 3,153.6365 shares.
NYSE
Director Ashley McEvoy reports acquiring 1,309 shares of Procter & Gamble common stock on October 8, 2024, through the company's 2019 Stock and Incentive Compensation Plan.
NYSE
Director Terry J. Lundgren reports acquiring 1,309 shares of Procter & Gamble common stock on October 8, 2024.
NYSE
Director Debra L. Lee reports acquiring 1,309 shares of Procter & Gamble common stock through restricted stock units.